These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3350977)
21. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation. Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795 [TBL] [Abstract][Full Text] [Related]
22. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis. Miller JJ; Olds LC; Silverman ED; Milgrom H; Curd JG Pediatr Res; 1986 Dec; 20(12):1332-7. PubMed ID: 3099253 [TBL] [Abstract][Full Text] [Related]
23. Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity. Kim SH; Jeong HJ Yonsei Med J; 2003 Feb; 44(1):75-80. PubMed ID: 12619178 [TBL] [Abstract][Full Text] [Related]
24. Complement activation products in plasma after heart transplantation in humans. Vallhonrat H; Williams WW; Dec GW; Keck S; Schoenfeld D; Cosimi AB; Pascual M Transplantation; 2001 May; 71(9):1308-11. PubMed ID: 11397968 [TBL] [Abstract][Full Text] [Related]
25. Activation of the complement system in systemic sclerosis. Relationship to clinical severity. Senaldi G; Lupoli S; Vergani D; Black CM Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products. Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449 [TBL] [Abstract][Full Text] [Related]
27. Immunoelectrophoretic analysis of C4 split products expressing D but not C epitopes: influence of storage, Ca2+ and Ca2+-chelating agents. Petersen NE; Folkersen J; Teisner B; Svehag SE Complement; 1985; 2(2-3):147-55. PubMed ID: 2417781 [TBL] [Abstract][Full Text] [Related]
28. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein. Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263 [TBL] [Abstract][Full Text] [Related]
29. Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy. Yamada T; Moroo I; Koguchi Y; Asahina M; Hirayama K Acta Neurol Scand; 1994 Jan; 89(1):42-6. PubMed ID: 8178627 [TBL] [Abstract][Full Text] [Related]
30. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis. Gupta N; Wakefield DN; Clapp WL; Garin EH Nefrologia; 2017; 37(1):78-86. PubMed ID: 27595516 [TBL] [Abstract][Full Text] [Related]
31. Complement activation before, during and after cardiopulmonary bypass. Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017 [TBL] [Abstract][Full Text] [Related]
32. Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba. Senaldi G; Peakman M; Alhaq A; Makinde VA; Tee DE; Vergani D J Clin Pathol; 1987 Oct; 40(10):1235-9. PubMed ID: 3680549 [TBL] [Abstract][Full Text] [Related]
33. Complement fragment C4d and Bb levels in inflammatory skin diseases (e.g. SLE, atopic dermatitis, erythroderma and pustulosis palmaris et plantaris) for assessment of complement activation. Takematsu H; Tagami H Tohoku J Exp Med; 1991 Apr; 163(4):263-8. PubMed ID: 1831937 [TBL] [Abstract][Full Text] [Related]
34. Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. Ajona D; Pajares MJ; Corrales L; Perez-Gracia JL; Agorreta J; Lozano MD; Torre W; Massion PP; de-Torres JP; Jantus-Lewintre E; Camps C; Zulueta JJ; Montuenga LM; Pio R J Natl Cancer Inst; 2013 Sep; 105(18):1385-93. PubMed ID: 23940286 [TBL] [Abstract][Full Text] [Related]
35. Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Sabharwal UK; Vaughan JH; Fong S; Bennett PH; Carson DA; Curd JG Arthritis Rheum; 1982 Feb; 25(2):161-7. PubMed ID: 7066047 [TBL] [Abstract][Full Text] [Related]
36. [In-vivo activation of the 4th component of the complement system (C4) in premature and term infants with generalized bacterial infections]. Nürnberger W; Stannigel H; Müntel V; Michelmann I; Wahn V; Göbel U Klin Padiatr; 1990; 202(3):141-6. PubMed ID: 2355716 [TBL] [Abstract][Full Text] [Related]
37. Classical Complement Pathway Activation in the Kidneys of Women With Preeclampsia. Penning M; Chua JS; van Kooten C; Zandbergen M; Buurma A; Schutte J; Bruijn JA; Khankin EV; Bloemenkamp K; Karumanchi SA; Baelde H Hypertension; 2015 Jul; 66(1):117-25. PubMed ID: 25941343 [TBL] [Abstract][Full Text] [Related]